BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21246090)

  • 1. On the mechanism of antifibrillatory effect of afobazole.
    Kryzhanovskyi SA; Stolyaruck VN; Vititnova MB; Tsorin IB; Seredenin SB
    Bull Exp Biol Med; 2010 Sep; 149(3):314-7. PubMed ID: 21246090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic properties of afobazole and other 2-mercaptobensimidazole derivatives].
    Turilova AI; Mozhaeva TIa
    Eksp Klin Farmakol; 2010 May; 73(5):8-11. PubMed ID: 20597362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Afobazole influence on antinociceptive properties of morphine].
    Kolik LG; Zhukov VN; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(1):22-3. PubMed ID: 19334506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Afobazole decreases motor side effects induced by haloperidol].
    Seredenin SB; Garibova TA; Kuznetsova AL; Voronin MV; Iarkova MA; Voronina TA
    Eksp Klin Farmakol; 2009; 72(1):15-8. PubMed ID: 19334504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific effects of selective anxiolytic afobazole on the cardiovascular system].
    Tsorin IB; Palka IP; Chichkanov GG
    Eksp Klin Farmakol; 2009; 72(1):41-5. PubMed ID: 19334510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Afobasol antifibrillation activity in animals with the intact and denervated myocardium].
    Stoliaruk VN; Vititnova MB; Tsorin IB; Kryzhanovskiĭ SA
    Vestn Ross Akad Med Nauk; 2010; (4):45-8. PubMed ID: 20540356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanism of anti-ischemic effects of afobazole.
    Seredenin SB; Tsorin IB; Vititnova MB; Stolyaruk VN; Chichkanov GG; Kryzhanovskii SA
    Bull Exp Biol Med; 2013 Oct; 155(6):760-3. PubMed ID: 24288760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroreceptor mechanisms of the afobazole effect].
    Seredenin SB; Voronin MV
    Eksp Klin Farmakol; 2009; 72(1):3-11. PubMed ID: 19334502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.
    Cuevas J; Behensky A; Deng W; Katnik C
    J Pharmacol Exp Ther; 2011 Oct; 339(1):152-60. PubMed ID: 21715562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of anti-ischemic effect of afobazole in experimental myocardial infarction.
    Kryzhanovskyi SA; Sorokina AV; Stolyaruck VN; Vititnova MB; Miroshkina IA; Tsorin IB; Durnev AD; Seredenin SB
    Bull Exp Biol Med; 2011 Jan; 150(3):316-9. PubMed ID: 21240343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke.
    Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
    J Neurochem; 2016 Nov; 139(3):497-509. PubMed ID: 27488244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Cytoprotective Properties of Afobazole in Streptozotocin Model of Diabetes.
    Ivanov SV; Ostrovskaya RU; Sorokina AV; Seredenin SB
    Bull Exp Biol Med; 2020 Oct; 169(6):783-786. PubMed ID: 33098515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-β25-35.
    Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
    J Pharmacol Exp Ther; 2013 Nov; 347(2):458-67. PubMed ID: 24006337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afobazole activation of σ-1 receptors modulates neuronal responses to amyloid-β25-35.
    Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
    J Pharmacol Exp Ther; 2013 Nov; 347(2):468-77. PubMed ID: 24006338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of antifibrillatory effects of drugs.
    Sugimoto T; Murakawa Y; Toda I
    Am J Cardiol; 1989 Dec; 64(20):33J-36J. PubMed ID: 2480706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the sympathetic nervous system activation on the antifibrillatory efficacy of various anti-arrhythmia agents].
    Kaverina NV; Chichkanov GG; Tsorin IB; Kirsanova GIu
    Eksp Klin Farmakol; 2000; 63(6):22-3. PubMed ID: 11202504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective Effect of Afobazole and Its Main Metabolite M-11.
    Kadnikov IA; Voronin MV; Seredenin SB
    Bull Exp Biol Med; 2015 May; 159(1):44-7. PubMed ID: 26033588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
    Cuevas J; Rodriguez A; Behensky A; Katnik C
    J Pharmacol Exp Ther; 2011 Oct; 339(1):161-72. PubMed ID: 21715561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.